Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank33
3Y CAGR-8.7%
5Y CAGR+12.0%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-8.7%/yr
Annual compound
5Y CAGR
+12.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.86M | -15.7% |
| 2024 | $20.00M | -19.8% |
| 2023 | $24.94M | +12.6% |
| 2022 | $22.15M | +31.2% |
| 2021 | $16.88M | +76.4% |
| 2020 | $9.57M | - |
| 2019 | $0.00 | - |